元宵
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
小小
Lv3
270 积分
2024-02-01 加入
最近求助
最近应助
互助留言
感染诱发的老年多脏器功能障碍综合征诊断与治疗中国指南2024
4小时前
已关闭
气管导管拔除的专家共识(2020版)
29天前
已完结
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: A position statement from the European Group for Blood and Marrow Transplantation
11个月前
已完结
Stem Cell Collection with Daratumumab (DARA)-Based Regimens in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) in the Griffin and Master Studies
11个月前
已关闭
Impact of Daratumumab on Stem Cell Collection, Graft Composition and Engraftment Among Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant
11个月前
已完结
On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost
11个月前
已完结
Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
11个月前
已完结
Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma
11个月前
已完结
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis
11个月前
已完结
Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF+/−plerixafor
11个月前
已完结
没有进行任何应助
已找到【积分已退回】
4小时前
原文在哪晓得不?
29天前
缺少大部分内容
11个月前
内容不完整啊
11个月前
点赞
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论